- Headquarters
- Shanghai
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- alphabiopharma.com
- Total Funding
- $73.0M
- Last Round
- $8.0M Series BApr 2022
- Rounds
- 2
About
专注于创新药物从临床研发到商业化运作成功;致力于开发临床急需的创新治疗药物
Summary
Alpha Biopharma is a Biotech company based in Shanghai, China, founded in 2017. It has raised $73.0M in total across 2 rounds, most recently a $8.0M Series B round in Apr 2022. Investors include Qiming VP, TF Capital and LYZZ Capital.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform